We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PRVA:NASDAQPrivia Health Group, Inc. analysis

Data as of Oct 20, 2026 - not real-time

Latest price
$23.02
Risk: medium
6/10Medium risk

Summary

At $23.02, Privia Health Group, Inc. shows a bearish moving-average alignment, with shorter averages beneath longer ones. It has gained 10.8% over the past 30 days. Momentum indicators put RSI at 74.9 (overbought) with MACD reading bullish. The recent range runs from support at $18.92 up to resistance at $23.06.
Multiples put this in fair territory: 109.6 times earnings against the sector's 32.0. Analyst price targets sit 36.7% above the current price. Revenue is growing at 21.4% on a 1.2% profit margin.
Risk comes out at 6 of a possible 10, a elevated reading. With 30-day volatility of 26.1%, a beta of 0.61 and a maximum drawdown of 32.0%, position sizing matters here. The wider market backdrop reads extreme greed at 90 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 1/10.

Top market events

  • In the past week, Privia Health Group, Inc.
  • Privia Health NASDAQ:PRVA just turned in a quarter that checked every box management set for itself, and then raised...
  • Privia Health NASDAQ:PRVA just turned in a quarter that checked every box management set for itself, and then raised...

Market outlook

Short term

< 1 year

Neutral

Model confidence2/102 out of 10

Key factors

  • Short-term moving averages stacked below long-term ones
  • RSI at 74.9 signals overbought conditions
  • Trading above the 200-day average of 22.72

Medium term

1–3 years

Neutral

Model confidence2/102 out of 10

Key factors

  • Short-term moving averages stacked below long-term ones
  • RSI at 74.9 signals overbought conditions
  • P/E of 109.6 versus sector average of 32.0

Long term

> 3 years

Neutral

Model confidence1/101 out of 10

Key factors

  • P/E of 109.6 versus sector average of 32.0
  • Analyst targets imply +36.7% versus the current price
  • Revenue growth of +21.4%

Key metrics

Financial health

Revenue Growth21.40%
Profit Margin1.19%
P/E Ratio109.6
ROE4.31%
ROA2.03%
Debt/Equity1.04
P/B Ratio3.7
Op. Cash Flow$131.1M
Free Cash Flow$95.6M
Industry P/E32.0

Technical analysis

TrendBearish
RSI74.9
Support$18.92
Resistance$23.06
MA 20$20.76
MA 50$20.80
MA 200$22.72
MACDBullish
VolumeStable
Fear & Greed Index89.84

Valuation

Fair Value$24.72
Target Price$31.47
Upside/Downside36.74%
GradeFair
TypeGrowth

Risk assessment

Beta0.61
Volatility26.12%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.